We have located links that may give you full text access.
Prevalence of female sexual dysfunction during pregnancy in Eastern Mediterranean Regional Office Countries (EMRO): a systematic review and meta-analysis.
BACKGROUND: Sexual dysfunction is potential abnormality in the ability of a person to sexual respond or enjoy sexual experience. During pregnancy, sexual function is at risk and disorder due to physical, hormonal and psychological changes. The prevalence of female sexual dysfunction is very variable during pregnancy.
OBJECTIVE: The aim of this study was to determine the prevalence of sexual dysfunction in pregnant women in the Eastern Mediterranean Regional Office Countries (EMRO) by meta-analysis and systematic methods.
MATERIALS AND METHODS: This study was reported based on the PRISMA checklist for systematic review and meta-analysis. This study investigated all articles with full English text in the EMRO region, from the international databases from 2000 to January 2019, which examined the prevalence of the sexual dysfunction in pregnant women. Statistical analysis was performed by using STATA12.1software.
RESULTS: The results reveal that the prevalence of the sexual dysfunction in pregnant women is65% (95% CI: 54-75%). The mean of total sexual dysfunction in women was 22.71 (95% CI: 18.52-28.51%) and for the first, second and third trimester of pregnancy were obtained as 23.77 (95% CI: 28.56-28.96%), 23.80 (95% CI: 23.78-23.82%) and 22.60 (95% CI: 22.58-22.62%), respectively.
CONCLUSION: The prevalence rate of sexual dysfunction is high in pregnant women in the EMRO region. The high rate of sexual dysfunction can be due to the difference in sexual performance scoring using the female sexual function questionnaire and on the other hand, pregnant women may be due to incorrect beliefs about sexual activity and cultural, religious and social restrictions and taboos, they have been avoiding to express their sexual function correctly.
OBJECTIVE: The aim of this study was to determine the prevalence of sexual dysfunction in pregnant women in the Eastern Mediterranean Regional Office Countries (EMRO) by meta-analysis and systematic methods.
MATERIALS AND METHODS: This study was reported based on the PRISMA checklist for systematic review and meta-analysis. This study investigated all articles with full English text in the EMRO region, from the international databases from 2000 to January 2019, which examined the prevalence of the sexual dysfunction in pregnant women. Statistical analysis was performed by using STATA12.1software.
RESULTS: The results reveal that the prevalence of the sexual dysfunction in pregnant women is65% (95% CI: 54-75%). The mean of total sexual dysfunction in women was 22.71 (95% CI: 18.52-28.51%) and for the first, second and third trimester of pregnancy were obtained as 23.77 (95% CI: 28.56-28.96%), 23.80 (95% CI: 23.78-23.82%) and 22.60 (95% CI: 22.58-22.62%), respectively.
CONCLUSION: The prevalence rate of sexual dysfunction is high in pregnant women in the EMRO region. The high rate of sexual dysfunction can be due to the difference in sexual performance scoring using the female sexual function questionnaire and on the other hand, pregnant women may be due to incorrect beliefs about sexual activity and cultural, religious and social restrictions and taboos, they have been avoiding to express their sexual function correctly.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app